[Clinical use of pentapyrrolidinium (M & B 2050 A) combined with Rauwolfia serpentina in the treatment of arterial hypertension].
D000959:Antihypertensive Agents; D002317:Cardiovascular Agents; D006973:Hypertension / Q000628:therapy*; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D011926:Rauwolfia; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central; D046948:Secologanin Tryptamine Alkaloids
HYPERTENSION/therapy; MUSCLE RELAXANTS/therapeutic use; RAUWOLFIA ALKALOIDS/therapeutic use
Uso clínico del pentapirrolidinium (M & B 2050 A) asociado a la Rauwolfia serpentina en el tratamiento de la hipertensión arterial.